Rock Musicians Rufus Wainwright, Lisa Loeb, Tim Reynolds and More to Perform Free Virtual Concert for Colorectal Cancer Awareness

The American College of Gastroenterology Invites All to “Tune It Up: A Concert To Raise Awareness of Colorectal Cancer” Free Webstream Event Open to All on March 31, 2021 at 8:00 pm EDT

Read more

GI OnDEMAND Announces Partnership with Ambry Genetics for Genetic Testing and Counseling Services

GI OnDEMAND®, gastroenterology’s leading multidisciplinary virtual integrated care platform today announced a partnership with Ambry Genetics®, a leading clinical genetic testing company, to integrate online genetic counseling and testing services into gastroenterology practices nationwide. This partnership addresses a critical clinical need for identifying hereditary GI cancer syndromes to help guide potentially life-altering health care decisions.
GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer the CARE (Comprehensive, Assessment, Risk, and Education) Program™ from Ambry Genetics.

Read more

American College of Gastroenterology Issues Updated Colorectal Cancer Screening Guidelines

The American College of Gastroenterology has issued updated evidence-based screening guidelines for colorectal cancer (CRC), including a new recommendation to begin CRC screening at age 45 for average risk adults. Key updates include recommendations for screening individuals with family history of CRC or polyps, guidance on the use of aspirin to reduce the risk of CRC, quality indicators for adenoma detection rate and colonoscopy withdrawal time, as well as suggestions about evidence-based interventions to boost screening rates, especially among African Americans. The authors distinguish between one-step screening tests, such as colonoscopy, and two-step screening tests that require colonoscopy, if positive, in order to complete the screening process.

Read more

Putting the Spotlight on Colorectal Cancer Risk and Prevention during Colorectal Cancer Awareness Month

Colorectal Cancer Screening Saves Lives Colorectal cancer is the third most common cause of cancer related death for both men

Read more

Year or More Delay Between Abnormal, At-Home Screening and Colonoscopy Increases Cancer Risk

A new study by researchers at University of California San Diego School of Medicine found delayed time between abnormal stool-based screening and subsequent colonoscopy was associated with an increased risk of a cancer diagnosis and death from colorectal cancer.

Read more

Strange colon discovery explains racial disparities in colorectal cancer

The colons of African-Americans and people of European descent age differently, new research reveals, helping explain racial disparities in colorectal cancer – the cancer that killed beloved “Black Panther” star Chadwick Boseman.

Read more

Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Read more

New combination therapy could help fight difficult-to-treat cancers with common mutations

UCLA scientists describe a new combination therapy that suppresses the MAPK pathway by holding cancer-driving proteins in a death grip. This combination of two small molecules has the potential to treat not only BRAF mutated melanoma but also additional aggressive subtypes of cancers, including melanoma, lung, pancreatic and colon cancers that harbor common mutations in cancer genes called RAS or NF1.

Read more

Colon cancer surgery performed by highly skilled surgeons improves long-term survival for patients

CHICAGO (October 30, 2020): Colon cancer patients achieve better five-year survival rates when the surgeons who treat them are rated as highly skilled, according to findings from what authors say is the first study to link a surgeon’s technical skills with improved long-term clinical outcomes. The study is published online in JAMA Oncology and virtually presented as part of the American College of Surgeons Commission on Cancer’s Annual Research Paper Competition.

Read more

Daily coffee consumption associated with improved survival in patients with metastatic colorectal cancer

In a large group of patients with metastatic colorectal cancer, consumption of a few cups of coffee a day was associated with longer survival and a lower risk of the cancer worsening, researchers at Dana-Farber Cancer Institute and other organizations report in a new study.

Read more

High-risk Patients for Colorectal Cancer Lack Knowledge About Colonoscopy

Many clinicians rely on self-reports from their high-risk patients about their need and proper interval for repeat surveillance colonoscopy. Researchers analyzed data over four years to explore the knowledge of these high-risk patients. Twenty-eight percent were unaware of either the need for a repeat colonoscopy or the proper surveillance interval. Of these, 16.6 percent were unaware of the proper three-year interval to obtain a follow-up surveillance colonoscopy. Also, 12 percent were not even aware that they required a follow-up surveillance colonoscopy.

Read more

Cancer health and education providers stress importance of colorectal cancer awareness following death of “Black Panther” actor

Colorectal cancer is the second-leading cause of cancer-related deaths in men and the third-leading cause of cancer-related deaths in women in the United States. Black people in the United States also have the highest rates of colorectal cancer of any racial or ethnic group, according to the American Cancer Society.

Read more

Leading Cancer Treatment Recommendations from NCCN Now Available in French, German, Italian, Portuguese, Russian, and Spanish

NCCN Guidelines, containing expert recommendations for cancer care, are available in French, German, Italian, Portuguese, Russian, and Spanish can all be accessed for free at NCCN.org/global or via the free Virtual Library of NCCN Guidelines® App

Read more

Center for Asian Health Equity awarded $4.25 million CDC grant to prevent colorectal cancer in Illinois

The University of Chicago Medicine’s Center for Asian Health Equity has received a five-year, $4.25 million federal grant to increase colorectal cancer screenings, particularly among underserved and rural Illinois communities.

Read more

Road Map to Reducing Colorectal Cancer Deaths

According to the American Gastroenterological Association’s recently published “Roadmap for the Future of Colorectal Cancer Screening in the United States, ” fewer people would die of colorectal cancer if health care providers adopted a new model of screening that combines better risk assessment, more options for noninvasive testing and more targeted referrals for colonoscopies. Rush University Medical Center’s Joshua Melson, MD is lead author.

Read more

MSK: Cancer Isn’t Sheltering in Place

As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, Memorial Sloan Kettering Cancer Center oncologists are urging patients to schedule cancer screenings and treatments now – as the long-term toll of missed diagnoses and delayed treatments could be devastating for patients and their loved ones across the region and the country.

Read more

Colorectal Cancer Q&A: The Truth about Screening, Prevention, and More

A colonoscopy is the best way to screen for and prevent colorectal cancer (CRC) because it allows your doctor to find and remove precancerous growths called polyps before they have a chance to turn into cancer.

The U.S. Preventive Services Task Force (USPSTF) recommends that most people have colonoscopy screenings starting at age 50. People who are at a higher risk for CRC due to family history or other factors should begin having screenings at a younger age based on their doctor’s recommendation.

Cologuard, an at-home test, is not a preventive CRC screening tool because it detects cancer after you develop it.

Read more

Researchers identify new therapeutic target for colorectal cancer

Researchers at the University of Toronto have identified a key protein that supports the growth of many colorectal cancers. The study, which will be published December 27 in the Journal of Cell Biology, reveals that a protein called Importin-11 transports the cancer-causing protein βcatenin into the nucleus of colon cancer cells, where it can drive cell proliferation. Inhibiting this transport step could block the growth of most colorectal cancers caused by elevated βcatenin levels.

Read more

Intestinal Stem Cell Genes May Link Dietary Fat and Colon Cancer

Two genes that appear to help stem cells in the intestine burn dietary fat may play a role in colon cancer, according to a Rutgers study. The study, published in the journal Gastroenterology, describes a new connection between the way cells consume fat and how genes regulate stem cell behavior in the intestines of mice.

Read more

American College of Gastroenterology Announces Winners of Fifth Annual SCOPY Awards

American College of Gastroenterology announces 2019 SCOPY Award winners (Service Award for Colorectal Cancer Outreach, Prevention, and Year-Round Excellence) to recognize the achievements of ACG members in their community engagement, education and awareness efforts for colorectal cancer prevention

Read more

Microbiome Provides New Clues to Determining Development of Colon Cancer

Findings showcasing a connection between bacteria in the microbiome and colon cancer, which may be used to screen younger populations at risk, were published in the journal Gastroenterology by researchers from the George Washington University.

Read more

Antibiotics exposure linked to increased colon cancer risk

In an extensive “data mining” analysis of British medical records, researchers at the Johns Hopkins Kimmel Cancer Center conclude that taking even a single course of antibiotics might boost—albeit slightly—the risk of developing colon cancer—but not rectal cancer—a decade later. The findings, reported in the August 20 issue of the journal Gut , highlight the need for judicious use of this broad category of drugs, which are frequently improperly or overprescribed, the report authors say.

Read more